209 related articles for article (PubMed ID: 12067091)
1. Misuse of randomization: a review of Chinese randomized trials of herbal medicines for chronic hepatitis B.
Liu J; Kjaergard LL; Gluud C
Am J Chin Med; 2002; 30(1):173-6. PubMed ID: 12067091
[TBL] [Abstract][Full Text] [Related]
2. Chinese medicinal herbs for chronic hepatitis B.
Liu JP; McIntosh H; Lin H
Cochrane Database Syst Rev; 2001; 2000(1):CD001940. PubMed ID: 11279742
[TBL] [Abstract][Full Text] [Related]
3. Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews.
He J; Du L; Liu G; Fu J; He X; Yu J; Shang L
Trials; 2011 May; 12():122. PubMed ID: 21569452
[TBL] [Abstract][Full Text] [Related]
4. Chinese medicinal herbs for chronic hepatitis B: a systematic review.
Liu J; McIntosh H; Lin H
Liver; 2001 Aug; 21(4):280-6. PubMed ID: 11454192
[TBL] [Abstract][Full Text] [Related]
5. Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review.
Zhang L; Wang G; Hou W; Li P; Dulin A; Bonkovsky HL
Hepatology; 2010 Feb; 51(2):690-8. PubMed ID: 20101751
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of RCTs and quasi-RCTs on traditional Chinese patent medicines for treatment of chronic hepatitis B.
Zhan T; Wei X; Chen ZQ; Wang DS; Dai XP
J Tradit Chin Med; 2011 Dec; 31(4):288-96. PubMed ID: 22462233
[TBL] [Abstract][Full Text] [Related]
7. [Xiaochaihu Tang for treatment of chronic hepatitis B: a systematic review of randomized trials].
Qin XK; Li P; Han M; Liu JP
Zhong Xi Yi Jie He Xue Bao; 2010 Apr; 8(4):312-20. PubMed ID: 20388470
[TBL] [Abstract][Full Text] [Related]
8. [Systematic evaluation of random controlled trial on treatment of chronic hepatitis B by Chinese herbal medicine].
Liu SP; Qin XK; McIntosh H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Jan; 22(1):58-62, 64. PubMed ID: 12585176
[No Abstract] [Full Text] [Related]
9. [Qualitative evaluation on literatures related with treatment of lung cancer with combined use of chemotherapy and Chinese herbs].
Liu YL; Xu K; Bai JP; Li LN; Yang XB
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Feb; 25(2):123-5. PubMed ID: 15768874
[TBL] [Abstract][Full Text] [Related]
10. Error Matrix Tool to Overview the Validity of Evidence on Radix
Liang N; Kong DZ; Ma SS; Lu CL; Yang M; Feng LD; Liu XH; Gluud C; Liu JP
J Altern Complement Med; 2019 Sep; 25(9):957-973. PubMed ID: 30883184
[No Abstract] [Full Text] [Related]
11. Hot topics in Chinese herbal drugs research documented in PubMed/MEDLINE by authors inside China and outside of China in the past 10 years: based on co-word cluster analysis.
Li HY; Cui L; Cui M
J Altern Complement Med; 2009 Jul; 15(7):779-85. PubMed ID: 19534611
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation on HBeAg conversion time when treating chronic hepatitis B patients with combination of lamivudine and traditional Chinese medicine].
Bai SL; Hu XY; Zhong S
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Dec; 29(12):1243-7. PubMed ID: 19173973
[TBL] [Abstract][Full Text] [Related]
13. Chinese herbal medicine and clomiphene citrate for anovulation: a meta-analysis of randomized controlled trials.
See CJ; McCulloch M; Smikle C; Gao J
J Altern Complement Med; 2011 May; 17(5):397-405. PubMed ID: 21563919
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary analysis on the method of efficacy evaluation used in clinical articles issued in Chinese journal of integrated traditional and Western medicine].
Li N; Xie ZF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Jan; 24(1):72-4. PubMed ID: 14976898
[No Abstract] [Full Text] [Related]
15. Anti-HBV effect of individual traditional Chinese herbal medicine in vitro and in vivo: an analytic review.
Chen Y; Zhu J
J Viral Hepat; 2013 Jul; 20(7):445-52. PubMed ID: 23730837
[TBL] [Abstract][Full Text] [Related]
16. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
McCulloch M; See C; Shu XJ; Broffman M; Kramer A; Fan WY; Gao J; Lieb W; Shieh K; Colford JM
J Clin Oncol; 2006 Jan; 24(3):419-30. PubMed ID: 16421421
[TBL] [Abstract][Full Text] [Related]
17. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
Pildal J; Hróbjartsson A; Jørgensen KJ; Hilden J; Altman DG; Gøtzsche PC
Int J Epidemiol; 2007 Aug; 36(4):847-57. PubMed ID: 17517809
[TBL] [Abstract][Full Text] [Related]
18. Placebo-controlled trials of Chinese herbal medicine and conventional medicine comparative study.
Shang A; Huwiler K; Nartey L; Jüni P; Egger M
Int J Epidemiol; 2007 Oct; 36(5):1086-92. PubMed ID: 17602184
[TBL] [Abstract][Full Text] [Related]
19. [Advances in studies on effect superiorities of traditional Chinese medicine on chronic hepatitis B].
Wang SL; Yao NL; Lv WL
Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2468-70. PubMed ID: 18330233
[TBL] [Abstract][Full Text] [Related]
20. Poor reporting quality of key Randomization and Allocation Concealment details is still prevalent among published RCTs in 2011: a review.
Clark L; Schmidt U; Tharmanathan P; Adamson J; Hewitt C; Torgerson D
J Eval Clin Pract; 2013 Aug; 19(4):703-7. PubMed ID: 23648066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
